NCT00134511View on ClinicalTrials.gov

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

November 30, 2005

Conditions
Hypercholesterolemia, Familial
Interventions
DRUG

Torcetrapib/atorvastatin

Trial Locations (6)

2193

Pfizer Investigational Site, Parktown

7925

Pfizer Investigational Site, Cape Town

9301

Pfizer Investigational Site, Bloemfontein

02114

Pfizer Investigational Site, Boston

G7H 5H6

Pfizer Investigational Site, Chicoutimi

G1V 4M6

Pfizer Investigational Site, Ste-Foy

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00134511 - Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder | Biotech Hunter | Biotech Hunter